{"entity":{"type":"insider","cik":"0001589095","url":"/insider/0001589095","json_url":"/insider/0001589095.json","name":"Versant Affiliates Fund V, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":7,"first":"2016-12-23","last":"2023-07-27","span_basis":"filed_date"},"name_variants":[{"name":"Versant Affiliates Fund V, L.P.","source":"filing","n_filings":7,"first_seen":"2016-12-23","last_seen":"2023-07-27"}],"transactions":[{"id":8629818,"accession":"0001209191-23-043527","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-23-043527","line_url":"/filing/0001209191-23-043527","is_derivative":false,"issuer_cik":"0001589095","issuer_name":"Turnstone Biologics Corp.","issuer_ticker":"TSBX","issuer_name_source":null,"issuer_url":"/issuer/0001589095","owner_cik":null,"owner_name":"Versant Ventures V (Canada), L.P.; Versant Venture Capital V, L.P.; Versant Ventures V, LLC; Versant Ventures V GP-GP (Canada), Inc.; Versant Vantage II GP, L.P.; Versant Vantage II, L.P.; Versant Venture Capital V (Canada), LP; Versant Ophthalmic Affiliates I, L.P.; Versant Vantage II GP-GP, LLC; Versant Affiliates Fund V, L.P.","owner_display_name":"Versant Ventures V (Canada), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":225000.0,"shares_display":"225,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2700000.0,"total_display":"2,700,000.00","total_whole":"2,700,000","shares_owned_after":2726322.0,"shares_owned_after_display":"2,726,322","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-25","filed_date":"2023-07-27","scope":"insider","n_lines":4},{"id":6560577,"accession":"0000899243-22-021348","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-021348","line_url":"/filing/0000899243-22-021348","is_derivative":false,"issuer_cik":"0001589095","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001589095","owner_cik":null,"owner_name":"Versant Ventures V, LLC; Versant Ventures VI GP, L.P.; Versant Ventures V GP-GP (Canada), Inc.; Versant Ophthalmic Affiliates I, L.P.; Versant Ventures V (Canada), L.P.; Versant Venture Capital V, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP-GP, LLC; Versant Venture Capital V (Canada), LP; Versant Affiliates Fund V, L.P.","owner_display_name":"Versant Ventures V, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750000.0,"shares_display":"750,000","price_per_share":12.2517,"price_display":"12.25","price_state":"stated","total_value":9188775.0,"total_display":"9,188,775.00","total_whole":"9,188,775","shares_owned_after":1464875.0,"shares_owned_after_display":"1,464,875","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-07","scope":"insider","n_lines":5},{"id":2966857,"accession":"0001209191-20-038990","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-20-038990","line_url":"/filing/0001209191-20-038990","is_derivative":false,"issuer_cik":"0001589095","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001589095","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures V, LLC; Versant Ventures VI GP, L.P.; Versant Affiliates Fund V, L.P.; Versant Ventures V GP-GP (Canada), Inc.; Versant Venture Capital V, L.P.; Versant Ventures V (Canada), L.P.; Versant Ophthalmic Affiliates I, L.P.; Versant Venture Capital V (Canada), LP","owner_display_name":"Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":608282.0,"shares_owned_after_display":"608,282","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-25","scope":"insider","n_lines":2},{"id":8425127,"accession":"0001140361-19-018090","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-19-018090","line_url":"/filing/0001140361-19-018090#line-3","is_derivative":false,"issuer_cik":"0001589095","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001589095","owner_cik":null,"owner_name":"Versant Affiliates Fund V, L.P.; Versant Ophthalmic Affiliates I, L.P.; Versant V Luxco S.a r.l.; Versant Venture Capital V (Canada), LP; Versant Venture Capital V, L.P.; Versant Ventures V (Canada), L.P.; Versant Ventures V GP-GP (Canada), Inc.; Versant Ventures V, LLC","owner_display_name":"Versant Affiliates Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333333.0,"shares_display":"333,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":333333.0,"shares_owned_after_display":"333,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-07","filed_date":"2019-10-07","scope":"insider"},{"id":6568756,"accession":"0000899243-18-010833","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-010833","line_url":"/filing/0000899243-18-010833","is_derivative":false,"issuer_cik":"0001589095","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001589095","owner_cik":null,"owner_name":"Versant Affiliates Fund V, L.P.; Versant Ophthalmic Affiliates I, L.P.; Versant Venture Capital V, L.P.; Versant Venture Capital V (Canada), LP; Versant Ventures V, LLC","owner_display_name":"Versant Affiliates Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22841.0,"shares_display":"22,841","price_per_share":50.98968521518322,"price_display":"50.99","price_state":"stated","total_value":1164655.4,"total_display":"1,164,655.40","total_whole":"1,164,655","shares_owned_after":1519505.0,"shares_owned_after_display":"1,519,505","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-24","filed_date":"2018-04-26","scope":"insider","n_lines":4},{"id":6537463,"accession":"0000899243-18-010684","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-18-010684","line_url":"/filing/0000899243-18-010684","is_derivative":false,"issuer_cik":"0001456589","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001456589","owner_cik":null,"owner_name":"Versant Venture Capital V (Canada), LP; Versant Venture Capital IV, L.P.; Versant Ventures IV, LLC; Versant Ophthalmic Affiliates I, L.P.; Versant Side Fund IV, L.P.; Versant Affiliates Fund V, L.P.; Versant Venture Capital V, L.P.","owner_display_name":"Versant Venture Capital V (Canada), LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101994.0,"shares_display":"101,994","price_per_share":50.6784844206522,"price_display":"50.68","price_state":"stated","total_value":5168901.34,"total_display":"5,168,901.34","total_whole":"5,168,901","shares_owned_after":1539576.0,"shares_owned_after_display":"1,539,576","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-24","scope":"insider","n_lines":4},{"id":9223374,"accession":"0001104659-16-163806","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-163806","line_url":"/filing/0001104659-16-163806","is_derivative":false,"issuer_cik":"0001456590","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001456590","owner_cik":null,"owner_name":"Versant Affiliates Fund V, L.P.; Versant Ophthalmic Affiliates I, L.P.; Versant Side Fund IV, L.P.; Versant Venture Capital IV, L.P.; Versant Venture Capital V (Canada), LP; Versant Venture Capital V, L.P.","owner_display_name":"Versant Affiliates Fund V, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":161000.0,"shares_display":"161,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":2254000.0,"total_display":"2,254,000.00","total_whole":"2,254,000","shares_owned_after":4104045.0,"shares_owned_after_display":"4,104,045","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-24","filed_date":"2016-12-23","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001764974","name":"Turnstone Biologics Corp.","url":"/issuer/0001764974","role":"Ten percent owner","n_filings":1,"first_seen":"2023-07-27","last_seen":"2023-07-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001808158","name":"Repare Therapeutics Inc.","url":"/issuer/0001808158","role":"Ten percent owner","n_filings":2,"first_seen":"2020-06-25","last_seen":"2022-06-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001781983","name":"Aprea Therapeutics, Inc.","url":"/issuer/0001781983","role":"Ten percent owner","n_filings":1,"first_seen":"2019-10-07","last_seen":"2019-10-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Ten percent owner","n_filings":3,"first_seen":"2016-12-23","last_seen":"2018-04-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001589095","retrieved_at":"2026-08-23T08:44:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}